Prior pulmonary disease history in patients, such as chronic obstructive pulmonary disease (COPD), was shown to be irrelevant to KRAS mutation in a study on 325 NSCLC patients, however there is insufficient evidence to support this claim [29]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.